Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Ocular gene therapies in clinical practice: viral vectors and nonviral alternatives.

Bordet T, Behar-Cohen F.

Drug Discov Today. 2019 Jun 5. pii: S1359-6446(18)30472-0. doi: 10.1016/j.drudis.2019.05.038. [Epub ahead of print] Review.

2.

Potential antiedematous effects of intravitreous anti-VEGF, unrelated to VEGF neutralization.

Behar-Cohen F, Dernigoghossian M, Andrieu-Soler C, Levy R, Cohen R, Zhao M.

Drug Discov Today. 2019 Jun 4. pii: S1359-6446(18)30471-9. doi: 10.1016/j.drudis.2019.05.034. [Epub ahead of print]

PMID:
31173913
3.

Ocular biocompatibility of dexamethasone acetate loaded poly(ɛ-caprolactone) nanofibers.

Rodrigues Da Silva G, Henrique Lima T, Maria Fernandes-Cunha G, Lambert Oréfice R, Da Silva-Cunha A, Zhao M, Behar-Cohen F.

Eur J Pharm Biopharm. 2019 May 23. pii: S0939-6411(18)31596-0. doi: 10.1016/j.ejpb.2019.05.010. [Epub ahead of print]

PMID:
31129274
4.

CENTRAL RETINAL VEIN OCCLUSION IN OTHERWISE HEALTHY CHILDREN AND ADOLESCENTS: Association With Multigenetic Variants of Thrombophilia.

Bremond-Gignac D, Daruich A, Gallet M, Menoud PA, Nowomiejska K, Rejdak R, Behar-Cohen F, Benkhalifa M, Copin H.

Retina. 2019 May 14. doi: 10.1097/IAE.0000000000002563. [Epub ahead of print]

PMID:
31095065
5.

Recent advances in slow and sustained drug release for retina drug delivery.

Behar-Cohen F.

Expert Opin Drug Deliv. 2019 Jun 10:1-8. doi: 10.1080/17425247.2019.1618829. [Epub ahead of print]

PMID:
31092046
6.

Corrigendum to "Cell Death Mechanisms in a Mouse Model of Retinal Degeneration in Spinocerebellar Ataxia 7" [Neuroscience 400C (2019) 72-84].

Lebon C, Behar-Cohen F, Torriglia A.

Neuroscience. 2019 Apr 15;404:558-564. doi: 10.1016/j.neuroscience.2019.01.058. Epub 2019 Feb 27. No abstract available.

PMID:
30825441
7.

Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration.

Zhao M, Mantel I, Gelize E, Li X, Xie X, Arboleda A, Seminel M, Levy-Boukris R, Dernigoghossian M, Prunotto A, Andrieu-Soler C, Rivolta C, Canonica J, Naud MC, Lechner S, Farman N, Bravo-Osuna I, Herrero-Vanrell R, Jaisser F, Behar-Cohen F.

Nat Commun. 2019 Jan 21;10(1):369. doi: 10.1038/s41467-018-08125-6.

8.

Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection.

Daruich A, Le Rouzic Q, Jonet L, Naud MC, Kowalczuk L, Pournaras JA, Boatright JH, Thomas A, Turck N, Moulin A, Behar-Cohen F, Picard E.

Sci Adv. 2019 Jan 9;5(1):eaau9940. doi: 10.1126/sciadv.aau9940. eCollection 2019 Jan.

9.

Cell Death Mechanisms in a Mouse Model of Retinal Degeneration in Spinocerebellar Ataxia 7.

Lebon C, Behar-Cohen F, Torriglia A.

Neuroscience. 2019 Feb 21;400:72-84. doi: 10.1016/j.neuroscience.2018.12.051. Epub 2019 Jan 6. Erratum in: Neuroscience. 2019 Apr 15;404:558-564.

PMID:
30625334
10.

CHANGES IN VISUAL ACUITY AND PHOTORECEPTOR DENSITY USING ADAPTIVE OPTICS AFTER RETINAL DETACHMENT REPAIR.

Potic J, Bergin C, Giacuzzo C, Daruich A, Pournaras JA, Kowalczuk L, Behar-Cohen F, Konstantinidis L, Wolfensberger TJ.

Retina. 2018 Nov 16. doi: 10.1097/IAE.0000000000002378. [Epub ahead of print]

PMID:
30475787
11.

Management of central serous chorioretinopathy: Expert panel discussion.

Chhablani J, Anantharaman G, Behar-Cohen F, Boon C, Manayath G, Singh R.

Indian J Ophthalmol. 2018 Dec;66(12):1700-1703. doi: 10.4103/ijo.IJO_1411_18. Review.

12.

Sun exposure to the eyes: predicted UV protection effectiveness of various sunglasses.

Backes C, Religi A, Moccozet L, Behar-Cohen F, Vuilleumier L, Bulliard JL, Vernez D.

J Expo Sci Environ Epidemiol. 2018 Oct 31. doi: 10.1038/s41370-018-0087-0. [Epub ahead of print] Review.

PMID:
30382242
13.

Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy.

Zola M, Daruich A, Matet A, Mantel I, Behar-Cohen F.

Br J Ophthalmol. 2018 Oct 24. pii: bjophthalmol-2018-312892. doi: 10.1136/bjophthalmol-2018-312892. [Epub ahead of print]

PMID:
30355720
14.

Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial.

Willcox A, Culliford L, Ellis L, Rogers CA, Cree A, Chakravarthy U, Ennis S, Behar-Cohen F, Reeves BC, Sivaprasad S, Lotery A.

Eye (Lond). 2019 Feb;33(2):295-303. doi: 10.1038/s41433-018-0212-2. Epub 2018 Sep 7.

15.

Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration.

Mantel I, Zola M, Mir O, Gaillard R, Behar-Cohen F.

Br J Ophthalmol. 2019 Jun;103(6):811-815. doi: 10.1136/bjophthalmol-2018-312318. Epub 2018 Jul 20.

16.

PATTERNS OF CHORIOCAPILLARIS FLOW SIGNAL VOIDS IN CENTRAL SEROUS CHORIORETINOPATHY: An Optical Coherence Tomography Angiography Study.

Matet A, Daruich A, Hardy S, Behar-Cohen F.

Retina. 2018 Jul 17. doi: 10.1097/IAE.0000000000002271. [Epub ahead of print]

PMID:
30028410
17.

Non-viral ocular gene therapy, pEYS606, for the treatment of non-infectious uveitis: Preclinical evaluation of the medicinal product.

Touchard E, Benard R, Bigot K, Laffitte JD, Buggage R, Bordet T, Behar-Cohen F.

J Control Release. 2018 Sep 10;285:244-251. doi: 10.1016/j.jconrel.2018.07.013. Epub 2018 Aug 1. Review.

PMID:
30009894
18.

Discrepancy in current central serous chorioretinopathy classification.

Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, Peiretti E, Sivaprasad S, Lotery AJ, Boon CJF, Behar-Cohen F, Freund KB, Chhablani J.

Br J Ophthalmol. 2019 Jun;103(6):737-742. doi: 10.1136/bjophthalmol-2018-312435. Epub 2018 Jul 12.

PMID:
30002069
19.

Towards an Optimized Use of Ocular Corticosteroids: EURETINA Award Lecture 2017.

Behar-Cohen F.

Ophthalmologica. 2018;240(2):111-119. doi: 10.1159/000489673. Epub 2018 Jun 28.

20.

Learning medial canthus retrobulbar anaesthesia for eye surgery: Ophthalmic surgeons versus anaesthetists.

Guerrier G, Rothschild PR, Lehmann M, Behar-Cohen F, Baillard C.

Anaesth Crit Care Pain Med. 2019 Apr;38(2):183-184. doi: 10.1016/j.accpm.2018.05.010. Epub 2018 Jun 2. No abstract available.

PMID:
29864549
21.

Topical Administration of Spironolactone-Loaded Nanomicelles Prevents Glucocorticoid-Induced Delayed Corneal Wound Healing in Rabbits.

Dahmana N, Mugnier T, Gabriel D, Kaltsatos V, Bertaim T, Behar-Cohen F, Gurny R, Kalia YN.

Mol Pharm. 2018 Mar 5;15(3):1192-1202. doi: 10.1021/acs.molpharmaceut.7b01028. Epub 2018 Feb 15.

PMID:
29397733
22.

Proteome and Metabolome of Subretinal Fluid in Central Serous Chorioretinopathy and Rhegmatogenous Retinal Detachment: A Pilot Case Study.

Kowalczuk L, Matet A, Dor M, Bararpour N, Daruich A, Dirani A, Behar-Cohen F, Thomas A, Turck N.

Transl Vis Sci Technol. 2018 Jan 18;7(1):3. doi: 10.1167/tvst.7.1.3. eCollection 2018 Jan.

23.

[AMD and complement pathway in 2017].

Behar-Cohen F.

Rev Med Suisse. 2018 Jan 10;14(588-589):64-69. French.

PMID:
29337453
24.

Mechanisms of macular edema: Beyond the surface.

Daruich A, Matet A, Moulin A, Kowalczuk L, Nicolas M, Sellam A, Rothschild PR, Omri S, Gélizé E, Jonet L, Delaunay K, De Kozak Y, Berdugo M, Zhao M, Crisanti P, Behar-Cohen F.

Prog Retin Eye Res. 2018 Mar;63:20-68. doi: 10.1016/j.preteyeres.2017.10.006. Epub 2017 Nov 7. Review.

25.

Irvine-Gass Macular Edema Responding to the Combination of Oral Mineralocorticoid-Receptor Antagonist With Dexamethasone Drops.

Matet A, Daruich A, Behar-Cohen F.

Ophthalmic Surg Lasers Imaging Retina. 2017 Nov 1;48(11):936-942. doi: 10.3928/23258160-20171030-11.

PMID:
29121365
26.

The Academic-Industrial Complexity: Failure to Launch.

Levin LA, Behar-Cohen F.

Trends Pharmacol Sci. 2017 Dec;38(12):1052-1060. doi: 10.1016/j.tips.2017.10.003. Epub 2017 Oct 27. Review.

27.

CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Matet A, Yzer S, Chew EY, Daruich A, Behar-Cohen F, Spaide RF.

Retina. 2018 Jan;38 Suppl 1:S67-S78. doi: 10.1097/IAE.0000000000001836.

28.

Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site.

Zhao M, Rodríguez-Villagra E, Kowalczuk L, Le Normand M, Berdugo M, Levy-Boukris R, El Zaoui I, Kaufmann B, Gurny R, Bravo-Osuna I, Molina-Martínez IT, Herrero-Vanrell R, Behar-Cohen F.

J Control Release. 2017 Nov 28;266:187-197. doi: 10.1016/j.jconrel.2017.09.029. Epub 2017 Sep 22.

PMID:
28947395
29.

ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy.

Rothschild PR, Salah S, Berdugo M, Gélizé E, Delaunay K, Naud MC, Klein C, Moulin A, Savoldelli M, Bergin C, Jeanny JC, Jonet L, Arsenijevic Y, Behar-Cohen F, Crisanti P.

Sci Rep. 2017 Aug 18;7(1):8834. doi: 10.1038/s41598-017-07329-y.

30.

Evaluation of tolerance to lentiviral LV-RPE65 gene therapy vector after subretinal delivery in non-human primates.

Matet A, Kostic C, Bemelmans AP, Moulin A, Rosolen SG, Martin S, Mavilio F, Amirjanians V, Stieger K, Lorenz B, Behar-Cohen F, Arsenijevic Y.

Transl Res. 2017 Oct;188:40-57.e4. doi: 10.1016/j.trsl.2017.06.012. Epub 2017 Jul 8.

31.

[Ophthalmology in 2016 : the advent of ocular biomarkers].

Matet A, Daruich A, Behar-Cohen F.

Rev Med Suisse. 2017 Jan 11;13(544-545):84-87. Review. French.

PMID:
28703544
32.

Effects of white light-emitting diode (LED) exposure on retinal pigment epithelium in vivo.

Jaadane I, Villalpando Rodriguez GE, Boulenguez P, Chahory S, Carré S, Savoldelli M, Jonet L, Behar-Cohen F, Martinsons C, Torriglia A.

J Cell Mol Med. 2017 Dec;21(12):3453-3466. doi: 10.1111/jcmm.13255. Epub 2017 Jun 29.

33.

RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY.

Matet A, Daruich A, Zola M, Behar-Cohen F.

Retina. 2018 Jul;38(7):1403-1414. doi: 10.1097/IAE.0000000000001729.

PMID:
28570485
34.

Central Serous Chorioretinopathy.

Daruich A, Matet A, Behar-Cohen F.

Dev Ophthalmol. 2017;58:27-38. doi: 10.1159/000455267. Epub 2017 Mar 28. Review.

PMID:
28351043
35.

Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants.

Fernandes-Cunha GM, Fialho SL, da Silva GR, Silva-Cunha A, Zhao M, Behar-Cohen F.

Pharm Res. 2017 May;34(5):1083-1092. doi: 10.1007/s11095-017-2118-2. Epub 2017 Feb 21.

PMID:
28224388
36.

Cone Genesis Tracing by the Chrnb4-EGFP Mouse Line: Evidences of Cellular Material Fusion after Cone Precursor Transplantation.

Decembrini S, Martin C, Sennlaub F, Chemtob S, Biel M, Samardzija M, Moulin A, Behar-Cohen F, Arsenijevic Y.

Mol Ther. 2017 Mar 1;25(3):634-653. doi: 10.1016/j.ymthe.2016.12.015. Epub 2017 Jan 28.

37.

ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.

Daruich A, Matet A, Marchionno L, De Azevedo JD, Ambresin A, Mantel I, Behar-Cohen F.

Retina. 2017 Oct;37(10):1905-1915. doi: 10.1097/IAE.0000000000001443.

38.

EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE.

Kowalczuk L, Matet A, Dirani A, Daruich A, Ambresin A, Mantel I, Spaide RF, Turck N, Behar-Cohen F.

Retina. 2017 Dec;37(12):2226-2237. doi: 10.1097/IAE.0000000000001424.

39.

Retinal safety of intravitreal rtPA in healthy rats and under excitotoxic conditions.

Daruich A, Parcq J, Delaunay K, Naud MC, Le Rouzic Q, Picard E, Crisanti P, Vivien D, Berdugo M, Behar-Cohen F.

Mol Vis. 2016 Nov 10;22:1332-1341. eCollection 2016.

40.

Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.

Nguyen QD, De Falco S, Behar-Cohen F, Lam WC, Li X, Reichhart N, Ricci F, Pluim J, Li WW.

Acta Ophthalmol. 2018 Feb;96(1):e1-e9. doi: 10.1111/aos.13325. Epub 2016 Nov 22. Review.

41.

Reply.

Bousquet E, Bergin C, Behar-Cohen F.

Am J Ophthalmol. 2016 Nov;171:151-152. doi: 10.1016/j.ajo.2016.08.011. No abstract available.

PMID:
27855849
42.

Postoperative Ocular Inflammation: A Single Subconjunctival Injection of XG-102 Compared to Dexamethasone Drops in a Randomized Trial.

Chiquet C, Aptel F, Creuzot-Garcher C, Berrod JP, Kodjikian L, Massin P, Deloche C, Perino J, Kirwan BA, de Brouwer S, Combette JM, Behar-Cohen F.

Am J Ophthalmol. 2017 Feb;174:76-84. doi: 10.1016/j.ajo.2016.10.012. Epub 2016 Nov 1.

43.

Light-induced retinal damage using different light sources, protocols and rat strains reveals LED phototoxicity.

Krigel A, Berdugo M, Picard E, Levy-Boukris R, Jaadane I, Jonet L, Dernigoghossian M, Andrieu-Soler C, Torriglia A, Behar-Cohen F.

Neuroscience. 2016 Dec 17;339:296-307. doi: 10.1016/j.neuroscience.2016.10.015. Epub 2016 Oct 14.

PMID:
27751961
44.

Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy.

Pichi F, Carrai P, Ciardella A, Behar-Cohen F, Nucci P; Central Serous Chorioretinopathy Study Group.

Int Ophthalmol. 2017 Oct;37(5):1115-1125. doi: 10.1007/s10792-016-0377-2. Epub 2016 Oct 18.

PMID:
27757733
45.

VOLUME-RENDERED ANGIOGRAPHIC AND STRUCTURAL OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF MACULAR TELANGIECTASIA TYPE 2.

Spaide RF, Suzuki M, Yannuzzi LA, Matet A, Behar-Cohen F.

Retina. 2017 Mar;37(3):424-435. doi: 10.1097/IAE.0000000000001344.

PMID:
27749698
46.

Seeing Early Signs of Alzheimer's Disease Through the Lens of the Eye.

Reed BT, Behar-Cohen F, Krantic S.

Curr Alzheimer Res. 2017;14(1):6-17. Review.

PMID:
27539593
47.

Amyloid Precursor-Like Protein 2 deletion-induced retinal synaptopathy related to congenital stationary night blindness: structural, functional and molecular characteristics.

Dinet V, Ciccotosto GD, Delaunay K, Borras C, Ranchon-Cole I, Kostic C, Savoldelli M, El Sanharawi M, Jonet L, Pirou C, An N, Abitbol M, Arsenijevic Y, Behar-Cohen F, Cappai R, Mascarelli F.

Mol Brain. 2016 Jun 8;9(1):64. doi: 10.1186/s13041-016-0245-z.

48.

Macular Telangiectasia Type 1: Capillary Density and Microvascular Abnormalities Assessed by Optical Coherence Tomography Angiography.

Matet A, Daruich A, Dirani A, Ambresin A, Behar-Cohen F.

Am J Ophthalmol. 2016 Jul;167:18-30. doi: 10.1016/j.ajo.2016.04.005. Epub 2016 Apr 12.

PMID:
27084003
49.

Anti-Inflammatory Effect of Dexamethasone Controlled Released From Anterior Suprachoroidal Polyurethane Implants on Endotoxin-Induced Uveitis in Rats.

Barbosa Saliba J, Vieira L, Fernandes-Cunha GM, Rodrigues Da Silva G, Ligório Fialho S, Silva-Cunha A, Bousquet E, Naud MC, Ayres E, Oréfice RL, Tekaya M, Kowalczuk L, Zhao M, Behar-Cohen F.

Invest Ophthalmol Vis Sci. 2016 Apr;57(4):1671-9. doi: 10.1167/iovs.15-18127.

PMID:
27054520
50.

Oral Mineralocorticoid-Receptor Antagonists: Real-Life Experience in Clinical Subtypes of Nonresolving Central Serous Chorioretinopathy With Chronic Epitheliopathy.

Daruich A, Matet A, Dirani A, Gallice M, Nicholson L, Sivaprasad S, Behar-Cohen F.

Transl Vis Sci Technol. 2016 Mar 4;5(2):2. eCollection 2016 Mar.

Supplemental Content

Loading ...
Support Center